Abstract
Key Points: • Genetic alterations in immune checkpoint–related genes are frequent in IVLBCL. • Plasma cfDNA is an alternative tumor DNA source of IVLBCL to detect genetic alterations by comprehensive analyses.
Original language | English |
---|---|
Pages (from-to) | 1491-1502 |
Number of pages | 12 |
Journal | Blood |
Volume | 137 |
Issue number | 11 |
DOIs | |
Publication status | Published - 18-03-2021 |
Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Biochemistry
- Immunology
- Hematology
- Cell Biology